Achieve Life Sciences Inc., a late-stage specialty pharmaceutical company, has appointed Erik Atkisson as chief legal officer.
Atkisson brings over 25 years of experience in the pharmaceutical and biotechnology industries. He joins Achieve as it advances its nicotine dependence and smoking cessation candidate, cytisinicline, through regulatory review and prepares for a potential launch.
He holds a JD from Georgetown University School of Law, an undergraduate degree from Harvard, and a master’s from the University of Edinburgh.
This story was produced by Bloomberg Law Automation.
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.